Breaking News Instant updates and real-time market news.

CELG

Celgene

$102.65

0.93 (0.91%)

17:41
01/19/18
01/19
17:41
01/19/18
17:41

Celgene's Abraxane exceeds primary endpoint target in pancreatic cancer trial

Celgene announced primary endpoint findings and updated results of secondary endpoints from the phase II international LAPACT trial of Abraxane plus gemcitabine in patients with locally advanced pancreatic cancer. An analysis of patients with newly diagnosed, locally advanced pancreatic cancer treated with up to 6 cycles of Abraxane plus gemcitabine as an investigational induction therapy found that patients had a median time to treatment failure of 8.8 months, which exceeded the protocol-specified target of 6.6 months. Secondary endpoints included evaluation of the disease control rate, overall response rate, progression free survival and overall survival in patients treated with an Abraxane plus gemcitabine induction therapy. One or more treatment emergent adverse event occurred in 99% of patients during induction. The most common adverse events were neutropenia, anemia and fatigue. In this prospective, phase II trial conducted in the US, Canada and Europe, patients with protocol-defined locally advanced, unresectable pancreatic cancer received an induction regimen of up to 6 cycles of Abraxane plus gemcitabine, followed by the investigator's choice of either continuation of the Abraxane plus gemcitabine regimen, treatment with chemoradiation, or surgery. More than half of patients completed the induction phase with Abraxane plus gemcitabine treatment. Forty two percent of patients did not complete induction treatment and the reasons for treatment discontinuation during induction included adverse events, progressive disease, protocol non-compliance, physician decision, death and other reasons.

  • 25

    Jan

  • 25

    Jan

  • 16

    Feb

  • 25

    Mar

CELG Celgene
$102.65

0.93 (0.91%)

01/17/18
JEFF
01/17/18
NO CHANGE
Target $125
JEFF
Buy
Jefferies believes $8B price tag makes sense for Juno Therapeutics
Jefferies analyst Michael Yee says that if Celgene (CELG) paid $65-$90 per share for Juno Therapeutics (JUNO), or a 50%-100% premium to the "unaffected" price before yesterday, it would equate to $7B-9B in enterprise value to consolidate. The analyst believes an $8B deal makes sense since Celgene owns 10% of Juno already. Assuming a $65-$90 per share deal price, the Street would view Juno as a positive "incremental" acquisition for Celgene, Yee tells investors in a research note. He keeps a Buy rating on Celgene with a $125 price target.
01/17/18
WELS
01/17/18
NO CHANGE
Target $63
WELS
Market Perform
Juno Therapeutics price target raised to $63 from $54 at Wells Fargo
Wells Fargo analyst Jim Birchenough raised his price target for Juno Therapeutics (JUNO) to $63 from $54 following a press report of potential acquisition interest by cell therapy partner Celgene (CELG). The analyst reiterates a Market Perform on Juno's shares.
01/17/18
CANT
01/17/18
NO CHANGE
CANT
Celgene acquisition of Juno 'doable' but questionable, says Cantor
Cantor Fitzgerald analyst Mara Goldstein maintained a Neutral rating and $112 price target on Celgene Corporation (CELG), noting that Celgene is reportedly in talks to buy the 90% of Juno Therapeutics (JUNO) that it does not already own. While Goldstein sees this potential acquisition as "doable," she questions whether it is "likely to provide a material enough offset near term to fully allay concerns regarding REVLIMID's patent expiration." In afternoon trading, Celgene shares have declined over 2.5%, while Juno shares have shot up over 49%.
01/18/18
SBSH
01/18/18
DOWNGRADE
Target $81
SBSH
Neutral
Citi downgrades Juno to Neutral, says potential takeover priced in
Citi analyst Robyn Karnauskas last night downgraded Juno Therapeutics (JUNO) to Neutral from Buy while raising her price target for the shares to $81 from $59. Juno closed yesterday up 52%, or $23.65, to $69.25 after the Wall Street Journal reported that Celgene (CELG) is in talks to acquire the company. When the story broke, Karnauskas said in a research note that Juno could be worth $110 per share in a takeover. She believes, however, that for Celgene, a deal makes sense in the $80-$85 per share range. The analyst expects Juno to trade with an M&A premium at $81 per share. With the recent 49% jump in shares, and the stock now trading within 17% of our takeover price, Karnauskas tells investors in a research note.

TODAY'S FREE FLY STORIES

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

, CHEF

Chefs' Warehouse

$19.45

-0.75 (-3.71%)

19:41
02/20/18
02/20
19:41
02/20/18
19:41
Hot Stocks
On The Fly: After Hours Movers »

UP AFTER EARNINGS: Verisk…

VRSK

Verisk Analytics

$97.04

-1.75 (-1.77%)

CHEF

Chefs' Warehouse

$19.45

-0.75 (-3.71%)

FLR

Fluor

$58.04

0.41 (0.71%)

RAS

RAIT Financial

$0.44

-0.031 (-6.56%)

EVBN

Evans Bancorp

$40.95

-1.55 (-3.65%)

CATM

Cardtronics

$24.69

-0.59 (-2.33%)

LC

LendingClub

$4.13

0.18 (4.56%)

BYD

Boyd Gaming

$37.60

0.26 (0.70%)

TXRH

Texas Roadhouse

$56.91

-1.07 (-1.85%)

PTLA

Portola Pharmaceuticals

$48.22

0.53 (1.11%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 20

    Feb

  • 21

    Feb

  • 25

    Feb

  • 26

    Feb

  • 28

    Feb

  • 07

    Mar

  • 15

    Mar

  • 04

    May

ANW

Aegean Marine

18:47
02/20/18
02/20
18:47
02/20/18
18:47
Earnings
Aegean Marine sees Q4 EPS (69c) with items, consensus 5c »

Q4 EPS was impacted by…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANW

Aegean Marine

18:44
02/20/18
02/20
18:44
02/20/18
18:44
Hot Stocks
Aegean Marine to acquire H.E.C. Europe for approximately $367M »

Aegean Marine is pleased…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TAHO

Tahoe Resources

$3.98

-0.15 (-3.63%)

18:31
02/20/18
02/20
18:31
02/20/18
18:31
Hot Stocks
Tahoe Resources announces results of PEA for la Arena II »

Tahoe Resources announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    Feb

PCH

Potlatch

$51.95

-2.8 (-5.11%)

, DEL

Deltic Timber

$93.28

-5.17 (-5.25%)

18:22
02/20/18
02/20
18:22
02/20/18
18:22
Hot Stocks
Potlatch, Deltic Timber completer merger, change name to PotlatchDeltic »

PotlatchDeltic announced…

PCH

Potlatch

$51.95

-2.8 (-5.11%)

DEL

Deltic Timber

$93.28

-5.17 (-5.25%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

  • 20

    Feb

NGD

New Gold

$2.58

-0.05 (-1.90%)

17:59
02/20/18
02/20
17:59
02/20/18
17:59
Hot Stocks
New Gold sees FY18 consolidated gold production 525,000-595,000 ounces »

Sees FY18 operating…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

NGD

New Gold

$2.58

-0.05 (-1.90%)

17:57
02/20/18
02/20
17:57
02/20/18
17:57
Earnings
New Gold reports Q4 adjusted EPS 6c, consensus 1c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

PSA

Public Storage

$186.31

-2.44 (-1.29%)

17:48
02/20/18
02/20
17:48
02/20/18
17:48
Earnings
Public Storage reports Q4 adjusted FFO $2.75, consensus $2.72 »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

HAIN

Hain Celestial

$34.68

-0.8 (-2.25%)

17:38
02/20/18
02/20
17:38
02/20/18
17:38
Hot Stocks
Breaking Hot Stocks news story on Hain Celestial »

Hain Celestial says…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

ESNT

Essent Group

$46.84

-0.39 (-0.83%)

17:38
02/20/18
02/20
17:38
02/20/18
17:38
Syndicate
Breaking Syndicate news story on Essent Group »

Essent Group files…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DHCP

Ditech

$10.57

0.34 (3.32%)

17:33
02/20/18
02/20
17:33
02/20/18
17:33
Hot Stocks
Breaking Hot Stocks news story on Ditech »

Lion Point reports 26.2%…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

SIEN

Sientra

$11.21

0.08 (0.72%)

17:32
02/20/18
02/20
17:32
02/20/18
17:32
Syndicate
Sientra enters into $50M At-the-Market equity offering sales agreement »

Sientra entered into an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 26

    Feb

ENLK

EnLink Midstream Partners

$16.36

0.03 (0.18%)

17:30
02/20/18
02/20
17:30
02/20/18
17:30
Earnings
EnLink Midstream Partners reports Q4 EPS 10c, consensus 6c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 02

    May

  • 01

    Aug

  • 07

    Nov

ENLC

EnLink Midstream

$16.90

0.15 (0.90%)

17:28
02/20/18
02/20
17:28
02/20/18
17:28
Earnings
EnLink Midstream reports Q4 EPS $1.12 with items, consensus 17c »

Reports Q revenue $1.76B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 26

    Feb

  • 02

    May

  • 01

    Aug

HAIN

Hain Celestial

$34.68

-0.8 (-2.25%)

17:23
02/20/18
02/20
17:23
02/20/18
17:23
Hot Stocks
Hain Celestial will look at divestitures and small acquisitions »

The company is presenting…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Feb

PGH

Pengrowth Energy

$0.73

0.0072 (0.99%)

17:17
02/20/18
02/20
17:17
02/20/18
17:17
Hot Stocks
Pengrowth Energy appoints Peter Sametz as CEO »

Pengrowth Energy…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

DVN

Devon Energy

$34.65

0.54 (1.58%)

17:15
02/20/18
02/20
17:15
02/20/18
17:15
Hot Stocks
Devon Energy sees accelerating growth in Delaware Basin in early FY18 »

The company states:…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

FTK

Flotek

$5.59

0.06 (1.09%)

17:15
02/20/18
02/20
17:15
02/20/18
17:15
Earnings
Flotek reports Q4 EPS (15c), two estimate consensus 3c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 21

    Feb

  • 23

    Feb

  • 15

    May

RCII

Rent-A-Center

$8.93

-0.62 (-6.49%)

17:14
02/20/18
02/20
17:14
02/20/18
17:14
Hot Stocks
Rent-A-Center sees FY18 free cash flow if at least $130M »

As the Company remains in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DVN

Devon Energy

$34.65

0.53 (1.55%)

17:13
02/20/18
02/20
17:13
02/20/18
17:13
Hot Stocks
Breaking Hot Stocks news story on Devon Energy »

Devon Energy Three-year…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

RCII

Rent-A-Center

$8.93

-0.62 (-6.49%)

17:12
02/20/18
02/20
17:12
02/20/18
17:12
Earnings
Rent-A-Center reports Q4 EPS (41c) ex-items, consensus (7c) »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

DVN

Devon Energy

$34.65

0.54 (1.58%)

17:12
02/20/18
02/20
17:12
02/20/18
17:12
Earnings
Devon Energy reports Q4 adjusted EPS 38c, consensus 63c »

Reports Q4 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 28

    Feb

GSS

Golden Star Resources

$0.73

-0.0013 (-0.18%)

17:07
02/20/18
02/20
17:07
02/20/18
17:07
Earnings
Golden Star Resources reports Q4 EPS 4c, consensus 2c »

Reports Q revenue $81.8M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

RAS

RAIT Financial

$0.44

-0.031 (-6.56%)

17:04
02/20/18
02/20
17:04
02/20/18
17:04
Hot Stocks
RAIT Financial concludes strategic, alternative review process »

RAIT Financial Trust…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MSA

MSA Safety

$76.46

-1.14 (-1.47%)

17:02
02/20/18
02/20
17:02
02/20/18
17:02
Hot Stocks
MSA Safety expects tailwind from U.S. tax reform during FY18 »

The company said,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 21

    Feb

  • 12

    Mar

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.